
### [NCIT:C4665](http://purl.obolibrary.org/obo/NCIT_C4665)
**Label:** Plasma Cell Neoplasm

**Subclasses:** [NCIT:C4734](http://purl.obolibrary.org/obo/NCIT_C4734) (Non-Secretory Plasma Cell Myeloma), [NCIT:C7813](http://purl.obolibrary.org/obo/NCIT_C7813) (Refractory Plasma Cell Neoplasm), [NCIT:C7765](http://purl.obolibrary.org/obo/NCIT_C7765) (Osteosclerotic Plasma Cell Myeloma), [NCIT:C7149](http://purl.obolibrary.org/obo/NCIT_C7149) (Smoldering Plasma Cell Myeloma), [NCIT:C7812](http://purl.obolibrary.org/obo/NCIT_C7812) (Solitary Osseous Plasmacytoma), [NCIT:C9349](http://purl.obolibrary.org/obo/NCIT_C9349) (Plasmacytoma), [NCIT:C6932](http://purl.obolibrary.org/obo/NCIT_C6932) (Solitary Plasmacytoma), [NCIT:C4002](http://purl.obolibrary.org/obo/NCIT_C4002) (Extraosseous Plasmacytoma), [NCIT:C7241](http://purl.obolibrary.org/obo/NCIT_C7241) (Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder), [NCIT:C3242](http://purl.obolibrary.org/obo/NCIT_C3242) (Plasma Cell Myeloma), [NCIT:C7240](http://purl.obolibrary.org/obo/NCIT_C7240) (Plasma Cell Post-Transplant Lymphoproliferative Disorder), [NCIT:C7242](http://purl.obolibrary.org/obo/NCIT_C7242) (Plasma Cell Myeloma Post-Transplant Lymphoproliferative Disorder), [NCIT:C118421](http://purl.obolibrary.org/obo/NCIT_C118421) (Anaplastic Plasmacytoma), [NCIT:C3180](http://purl.obolibrary.org/obo/NCIT_C3180) (Plasma Cell Leukemia), 

**Class expressions from DL-Learner:**

- [CL:0000786](http://purl.obolibrary.org/obo/CL_0000786) (plasma cell) 60.00%
- [NCIT:C41032](http://purl.obolibrary.org/obo/NCIT_C41032) (Bone Marrow-Homing Plasma Cell) 55.00%
- Thing 53.22%
- [CL:0000946](http://purl.obolibrary.org/obo/CL_0000946) (antibody secreting cell) 50.82%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 34.61%
- [CL:0000945](http://purl.obolibrary.org/obo/CL_0000945) (lymphocyte of B lineage) 24.74%
- [CL:0000542](http://purl.obolibrary.org/obo/CL_0000542) (lymphocyte) 20.31%
- [CL:0002242](http://purl.obolibrary.org/obo/CL_0002242) (nucleate cell) 20.21%
- [CL:0000219](http://purl.obolibrary.org/obo/CL_0000219) (motile cell) 19.13%
- [CL:0002371](http://purl.obolibrary.org/obo/CL_0002371) (somatic cell) 15.66%
- [CL:0000255](http://purl.obolibrary.org/obo/CL_0000255) (eukaryotic cell) 15.41%
- [CL:0000003](http://purl.obolibrary.org/obo/CL_0000003) (native cell) 15.21%
- [GO:0005623](http://purl.obolibrary.org/obo/GO_0005623) (cell) 15.20%
- [CL:0000000](http://purl.obolibrary.org/obo/CL_0000000) (cell) 15.09%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 15.03%


